Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

In GDP, what is the difference between “Validation” and “Qualification”? Which systems or equipment require them?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q325 · Category G: Quality management and compliance systems (Q301–Q350)
“Qualification” and “validation” both demonstrate that a system, equipment or process can consistently achieve its intended results, but they have different emphases. “Qualification” is usually applied to equipment, facilities and systems. It demonstrates that the “hardware” itself has been installed correctly, operates correctly and is suitable for its intended use. It usually comprises four stages: design qualification (DQ), installation qualification (IQ), operational qualification (OQ) and performance qualification (PQ). Qualification of a new refrigerator is one example. “Validation” focuses more on the “process”: it demonstrates that a complete process or method can consistently produce results that meet predetermined standards. Examples include transport validation of a cold-chain packaging solution and validation of a computerised system. In short, qualification is the foundation for validation: equipment is usually qualified first, followed by validation of the processes that use it.

📘 Regulatory basis

The Good Distribution Practice (GDP) for Medicinal Products requires critical equipment affecting the quality of medicines (such as cold rooms and refrigerators) and computerised systems to be qualified or validated before use, to demonstrate their suitability. Requalification or revalidation may be required after any significant change.

📗 Drew Tang's recommendations

We recommend that clients use a risk-based approach to determine the scope and depth of validation/qualification. Critical systems that directly affect product quality, such as temperature control systems and warehouse management systems (WMS), must undergo rigorous validation/qualification. All activities should be planned in advance in a protocol, followed by a report, with a complete documentary record. As this work requires specialist expertise, you may wish to engage a specialist third-party service provider to assist.

📕 Risk notice

Using critical equipment or systems that have not been qualified or validated is a serious GDP breach. For example, if you use an unqualified refrigerator to store vaccines, you will be unable to demonstrate to the regulator that their quality was maintained during storage. This may result in an entire batch being deemed non-conforming and put your licence at risk.

Back to Category G: Quality Management and Compliance Systems (Q301-Q350) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗